Niox Group (NIOX)

Sector:

Health Care

Index:

FTSE AIM 50

71.40p
   
  • Change Today:
    -0.80p
  • 52 Week High: 76.00p
  • 52 Week Low: 54.60p
  • Currency: UK Pounds
  • Shares Issued: 417.88m
  • Volume: 128,210
  • Market Cap: £298.37m
  • Beta: 0.81

Circassia shares plunge as its partner terminates agreement

By Josh White

Date: Thursday 19 Dec 2019

LONDON (ShareCast) - (Sharecast News) - Specialty biopharmaceutical company Circassia Pharmaceuticals updated the market on its licensing agreement with BeyondAir, previously AIT Therapeutics, on Thursday.
The AIM-traded firm said the agreement was for the commercial rights to the late-stage ventilator-compatible nitric oxide product 'LungFit PH', previously AirNOvent, in the United States and China.

"Circassia has received a notice from BeyondAir stating that it has terminated the agreement for material breach," the board said in its statement.

"Circassia refutes the allegations in the strongest terms and believes there are no grounds to terminate the agreement.

"The company will enforce its rights under the agreement and defend its position vigorously."

At 1635 GMT, shares in Circassia Pharmaceuticals were down 11% at 18.6p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Niox Group Market Data

Currency UK Pounds
Share Price 71.40p
Change Today -0.80p
% Change -1.11 %
52 Week High 76.00p
52 Week Low 54.60p
Volume 128,210
Shares Issued 417.88m
Market Cap £298.37m
Beta 0.81

Niox Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.76% below the market average90.76% below the market average90.76% below the market average90.76% below the market average90.76% below the market average
75.76% below the sector average75.76% below the sector average75.76% below the sector average75.76% below the sector average75.76% below the sector average
Price Trend
43.24% above the market average43.24% above the market average43.24% above the market average43.24% above the market average43.24% above the market average
77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average
Income
83.52% below the market average83.52% below the market average83.52% below the market average83.52% below the market average83.52% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Growth
47.07% above the market average47.07% above the market average47.07% above the market average47.07% above the market average47.07% above the market average
2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Niox Group Dividends

  Latest Previous
  Final Final
Ex-Div 15-May-25 23-May-24
Paid 16-Jun-25 24-Jun-24
Amount 1.25p 1.00p

Trades for 28-Nov-2025

Time Volume / Share Price
16:35 23,718 @ 71.40p
16:35 1 @ 71.40p
16:35 104 @ 71.40p
16:35 37 @ 71.40p
16:35 76 @ 71.40p

Niox Group Key Personnel

CEO Jonathan Emms
CFO Sarah Duncan

Top of Page